Letters to the Editor
NSAIDs Should Not Be Used in Treatment of Stress Fractures
FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.
FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.
Am Fam Physician. 2004 Oct 15;70(8):1452-1454.
to the editor: The article by Drs. Sanderlin and Raspa, “Common Stress Fractures,”1 reports, quite correctly, on the frequency and potential seriousness of stress fractures. We compliment American Family Physician for making it the cover article of the October 15, 2003, issue. However, we feel a need to comment on the author’s recommendation of the use of nonsteroidal anti-inflammatory drugs (NSAIDs) as a treatment for stress fractures.
The article repeatedly lists NSAIDs as a recommended treatment for “all stress fractures.” We are unaware of any data that suggest that NSAIDs are beneficial in the treatment of stress fractures. In fact, there is an increasing amount of literature suggesting that they may be harmful. A retrospective study of a cohort of more than 700,000 cases found that regular use of NSAIDs was associated with a 1.47 relative risk of nonvertebral fractures compared with control patients who did not receive NSAIDs.2 Another study compared 32 patients with nonunion of femoral fractures with 67 patients whose fractures had united. The results demonstrated a “marked association” between nonunion and the use of NSAIDs.3 These retrospective analyses are consistent with some prospective animal data demonstrating that NSAIDs retard fracture healing.4 Finally, it has been well established that NSAIDs inhibit heterotopic ossification (i.e., new bone formation) after total hip replacement and acetabular fractures.5
There is biologic plausibility for a detrimental effect of NSAIDs on bone healing. Inflammation is a necessary step in the healing of normal body tissues, and osteoblasts specifically require prostaglandins for osteogenesis and differentiation. By inhibiting these prostaglandins, NSAIDs may delay osteoblastic formation of new bone.
Additionally, NSAIDs have a strong analgesic effect. The article1 correctly encourages using the symptom of pain as a guide to increasing activity. A 10-year review6 of stress fractures in varsity athletes at the University of Minnesota validates this recommendation. While we want our patients to be pain free, masking the pain of stress fractures may compromise recovery. This is especially true of more dangerous stress fractures such as those of the femoral neck.
In our clinical practices we discourage the use of NSAIDs in patients with stress fractures. Based on our understanding of the physiology of bone healing and the clinical data available, we urge your readers to do the same.
1. Sanderlin BW, Raspa RF. Common stress fractures. Am Fam Physician. 2003;68:1527–32.
2. Van Staa TP, Leufkens HG, Cooper C. Use of nonsteroidal anti-inflammatory drugs and risk of fractures. Bone. 2000;27:563–8.
3. Giannoudis PV, MacDonald DA, Matthews SJ, Smith RM, Furlong AJ, De Boer P. Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs. J Bone Joint Surg Br. 2000;82:655–8.
4. Altman RD, Latta LL, Keer R, Renfree K, Hornicek FJ, Banovac K. Effect of nonsteroidal antiinflammatory drugs on fracture healing: a laboratory study in rats. J Orthop Trauma. 1995;9:392–400.
5. Vielpeau C, Joubert JM, Hulet C. Naproxen in the prevention of heterotopic ossification after total hip replacement. Clin Orthop. 1999;369:279–88.
6. Arendt E, Agel J, Heikes C, Griffiths H. Stress injuries to bone in college athletes: a retrospective review of experience at a single institution. Am J Sports Med. 2003;31:959–68.
editor’s note: This letter was sent to the authors of “Common Stress Fractures,” who declined to reply.
Send letters to Kenneth W. Lin, MD, MPH, Associate Deputy Editor for AFP Online, e-mail: email@example.com, or 11400 Tomahawk Creek Pkwy., Leawood, KS 66211-2680.
Please include your complete address, e-mail address, and telephone number. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors.
Letters submitted for publication in AFP must not be submitted to any other publication. Possible conflicts of interest must be disclosed at time of submission. Submission of a letter will be construed as granting the American Academy of Family Physicians permission to publish the letter in any of its publications in any form. The editors may edit letters to meet style and space requirements.
Copyright © 2004 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions